These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 12730674)

  • 21. Reconstitution of gene expression from a regulatory-protein-deficient hepatitis B virus genome by cell-permeable HBx protein.
    Hafner A; Brandenburg B; Hildt E
    EMBO Rep; 2003 Aug; 4(8):767-73. PubMed ID: 12872136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The PreS2 activators of the hepatitis B virus: activators of tumour promoter pathways.
    Hildt E; Hofschneider PH
    Recent Results Cancer Res; 1998; 154():315-29. PubMed ID: 10027012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation and inhibition of cellular calcium and tyrosine kinase signaling pathways identify targets of the HBx protein involved in hepatitis B virus replication.
    Bouchard MJ; Puro RJ; Wang L; Schneider RJ
    J Virol; 2003 Jul; 77(14):7713-9. PubMed ID: 12829810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of Src family kinases by hepatitis B virus HBx protein and coupled signaling to Ras.
    Klein NP; Schneider RJ
    Mol Cell Biol; 1997 Nov; 17(11):6427-36. PubMed ID: 9343405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Src kinases involved in hepatitis B virus replication.
    Klein NP; Bouchard MJ; Wang LH; Kobarg C; Schneider RJ
    EMBO J; 1999 Sep; 18(18):5019-27. PubMed ID: 10487754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis B virus X protein stimulates the mitochondrial translocation of Raf-1 via oxidative stress.
    Chen J; Siddiqui A
    J Virol; 2007 Jun; 81(12):6757-60. PubMed ID: 17428866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unraveling the complexities of the Raf/MAP kinase pathway for pharmacological intervention.
    Herrera R; Sebolt-Leopold JS
    Trends Mol Med; 2002; 8(4 Suppl):S27-31. PubMed ID: 11927284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increasing complexity of the Ras signaling pathway.
    Vojtek AB; Der CJ
    J Biol Chem; 1998 Aug; 273(32):19925-8. PubMed ID: 9685325
    [No Abstract]   [Full Text] [Related]  

  • 29. Structure-Guided Approach to Identify Potential Inhibitors of Large Envelope Protein to Prevent Hepatitis B Virus Infection.
    Mehmankhah M; Bhat R; Anvar MS; Ali S; Alam A; Farooqui A; Amir F; Anwer A; Khan S; Azmi I; Ali R; Ishrat R; Hassan MI; Minuchehr Z; Kazim SN
    Oxid Med Cell Longev; 2019; 2019():1297484. PubMed ID: 31772697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The mechanism of TiaoGanYiPi formula for treating chronic hepatitis B by network pharmacology and molecular docking verification.
    Cao X; Zao X; Xue B; Chen H; Zhang J; Li S; Li X; Zhu S; Guo R; Li X; Ye Y
    Sci Rep; 2021 Apr; 11(1):8402. PubMed ID: 33863948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Hepatitis Viruses on the Nrf2/Keap1-Signaling Pathway and Its Impact on Viral Replication and Pathogenesis.
    Bender D; Hildt E
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31546975
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HBV infection increases the risk of macular degeneration: the roles of HBx-mediated sensitization of retinal pigment epithelial cells to UV and blue light irradiation.
    Chou RH; Lee CY; Chong LW; Chang KH; Lin CL; Yan KS; Tsou C; Hsu YC
    J Transl Med; 2018 Aug; 16(1):221. PubMed ID: 30097062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evolving role of Sorafenib in the management of hepatocellular carcinoma.
    Ziogas IA; Tsoulfas G
    World J Clin Oncol; 2017 Jun; 8(3):203-213. PubMed ID: 28638790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of Hepatitis B Virus Large Surface Protein Using a Time-Resolved Immunofluorometric Assay.
    Hu Z; Li M; Liu J; Yu L; Xue Y; Chen Y
    J Clin Lab Anal; 2015 Nov; 29(6):498-504. PubMed ID: 25277704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular targeting agents associated with transarterial chemoembolization or radiofrequency ablation in hepatocarcinoma treatment.
    Ranieri G; Marech I; Lorusso V; Goffredo V; Paradiso A; Ribatti D; Gadaleta CD
    World J Gastroenterol; 2014 Jan; 20(2):486-97. PubMed ID: 24574717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification and characterization of a novel bipartite nuclear localization signal in the hepatitis B virus polymerase.
    Lupberger J; Schaedler S; Peiran A; Hildt E
    World J Gastroenterol; 2013 Nov; 19(44):8000-10. PubMed ID: 24307793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The MAPK MEK1/2-ERK1/2 Pathway and Its Implication in Hepatocyte Cell Cycle Control.
    Guégan JP; Frémin C; Baffet G
    Int J Hepatol; 2012; 2012():328372. PubMed ID: 23133759
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HBx induces HepG-2 cells autophagy through PI3K/Akt-mTOR pathway.
    Wang P; Guo QS; Wang ZW; Qian HX
    Mol Cell Biochem; 2013 Jan; 372(1-2):161-8. PubMed ID: 23001846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sorafenib for treatment of hepatocellular carcinoma: a systematic review.
    Xie B; Wang DH; Spechler SJ
    Dig Dis Sci; 2012 May; 57(5):1122-9. PubMed ID: 22451120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HBV life cycle: entry and morphogenesis.
    Schädler S; Hildt E
    Viruses; 2009 Sep; 1(2):185-209. PubMed ID: 21994545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.